This webinar will provide practical insights into evolving EU MDR clinical pathways, with real-world examples and key pitfalls from pre-clinical to post-market phases, including emerging routes like orphan and breakthrough devices.
The EU regulatory landscape for medical devices can seem like a complex path dotted with curveballs along the way. New MDCG guidance, as well as the latest MDR update proposal, lead to a rapid pace of changes to background information. Our clinical team at TÜV SÜD will present a practical breakdown of the available clinical regulatory pathways, stripping each step of the clinical pathway down to its bare essentials to put each component into perspective. We will provide positive and negative real-world examples of MDR compliance, from pre-clinical data requirements to a fully established clinical evaluation, and the pitfalls of the post-market phase. And how new pathways, such as orphan and breakthrough device status, will be integrated into the current landscape of clinical evaluation routes. This session aims to provide clarity and a greater understanding of an important aspect of a medical device’s regulatory journey.
Regulatory, clinical, and quality professionals, as well as medical device manufacturers involved in MDR clinical evaluation submissions, would benefit from attending.
Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].



Clinical Reviewer, TUV SUD
Surash Surash, FRCS (Neuro Surg), MD, LLM, Clinical Reviewer, UK, TÜV SÜD Dr. Surash Surash is a Clinical Reviewer working at the Centre for Clinical Excellence at TÜV SÜD. He previously served as a Consultant Neurosurgeon in the United Kingdom before moving into the field of medical device regulatory affairs. With extensive neurosurgical research experience, Dr. Surash published and presented internationally and was previously the associate editor of the British Journal of Neurosurgery. He also has a law degree (LLM) and has litigation experience in clinical negligence. Dr. Surash is an authorized clinical reviewer in both the EU MDR and the UK and is the clinical subject matter expert for orphan medical devices and In Silico methodologies at TÜV SÜD. He is also a member of the EU COMBINE, Virtual Human Twin, and BRIDGE -IHI projects and the Avicenna Alliance standards and NB task force. In 2025, he led the Whitepaper ‘In Silico methodologies – a Notified Body’s perspective on medical device approval.

Global Director and Head of the Clinical Centre of Excellence, TUV SUD
Moderator Dr. Ulrich Nitsche, M.D., Ph.D. Global Director & Head, Clinical Centre of Excellence, TÜV SÜD Dr. Ulrich Nitsche, M.D./Ph.D., is Global Director and Head of the Clinical Centre of Excellence, managing all internal and external clinicians for the notified bodies TÜV SÜD NB0123, TÜV SÜD NB2443, and the approved body TÜV SÜD AB0168. Besides his work as an internal clinician, Ulrich Nitsche is a member of the German Institute for Standardisation (DIN-Normenausschuss) in the Clinical Trials / Clinical Evaluation Working Group. In addition, he is a member of the Ethics Committee of the Technical University of Munich and of the Specialised Ethics Committee for Special Procedures of the BfArM. Ulrich Nitsche is a board-certified visceral surgeon and active emergency physician as well as medical incident Commander (senior emergency physician).
We have completed our migration to a new platform and are pleased to introduce the updated site.
What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.
We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.
We welcome your feedback. Please let us know how we can continue to improve your experience.